Burden of illness of diabetic macular edema: Literature review

Current Medical Research and Opinion

Volumn 26, Issue 7, 2010, Pages 1587-1597

  Chen, Er ^a   Looman, Mark ^a   Laouri, Marianne ^a   Gallagher, Meghan ^b   Van Nuys, Karen ^c   Lakdawalla, Darius ^d,e   Fortuny, Joan ^f  

^a Quorum Consulting   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c PRECISION HEALTH ECONOMICS   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e RAND CORPORATION   (United States)

^f Unidad de Health Outcomes Research   (Spain)

Author keywords

Burden of illness; Cost; Diabetic macular edema; Incidence; Prevalence; Quality of life

Indexed keywords

INSULIN;

DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; ELECTRONIC MEDICAL RECORD; EUROPE; FLUORESCENCE ANGIOGRAPHY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; QUALITY OF LIFE; REVIEW; UNITED STATES; COMPLICATION; COST OF ILLNESS; ECONOMICS; EVALUATION STUDY; MACULAR EDEMA; PATHOLOGY; TREATMENT OUTCOME;

COST OF ILLNESS; DIABETIC RETINOPATHY; EUROPE; HUMANS; MACULAR EDEMA; PREVALENCE; QUALITY OF LIFE; TREATMENT OUTCOME; UNITED STATES;

EID: 77953555650     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.482503     Document Type: Review

References (47)

1. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern® Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008. Available at: http://www.aao.org/ppp [Last accessed 2 February 2010]
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21:1414-1431
3. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27: 1047-1053
4. Diabetes Statistics. American Diabetes Association. Available at: http://www.diabetes.org/diabetes-statistics.jsp 2009. [Last accessed 2 February 2010]
5. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984; 91:1464-1474
6. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98: 741-756
7. Williams R, Airey M, Baxter H, et al. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004;18:963-983
8. Hirai FE, Knudtson MD, Klein BE, et al. Clinically significant macular edema and survival in type 1 and type 2 diabetes. Am J Ophthalmol 2008;145:700-706
9. Knudsen LL, Lervang HH, Lundbye-Christensen S, et al. The North Jutland County Diabetic Retinopathy Study: population characteristics. Br J Ophthalmol 2006;90:1404-1409
10. Knudsen LL, Lervang HH, Lundbye-Christensen S, et al. The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema. Br J Ophthalmol 2007; 91:1593-1595
11. Broadbent DM, Scott JA, Vora JP, et al. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye 1999; 13:160-165
12. Ling R, RamsewakV, Taylor D, etal. Longitudinal study of a cohort of people with diabetes screened by the Exeter Diabetic Retinopathy Screening Programme. Eye 2002;16:140-145
13. Reuterving CO, Kratholm J, Wachtmeister L. Ophthalmic health care in diabetes mellitus: a cross-sectional study in northern Sweden. Ophthalmic Epidemiol 1999;6:267-278
14. Romero-Aroca P, Fernandez-Alart J, Baget-Bernaldiz M, et al. Diabetic retinopathy epidemiology in type 2 diabetic patients. Effect of the changes in the diagnostic criteria and stricter control of the diabetes between 1993 and 2005 on the incidence of diabetic retinopathy. Arch Soc Esp Oftalmol 2007;82:209-218
15. WongTY, Klein R, Islam FM, etal. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006;141:446-455
16. Blum M, Kloos C, Muller N, et al. Prevalence of diabetic retinopathy. Check-up program of a public health insurance company in Germany 2002-2004. Ophthalmologe 2007;104:499-500, 502-504
17. Klein R, Davis MD, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons. Adv Exp Med Biol 1985;189:321-335
18. Future sight loss in the decade 2010 to 2020: an epidemiological and economic model. Report prepared for RNIB by Darwin Minassian and Angela Reidy. July 2009. EpiVision. Available at: http://www.vision2020uk. org.uk/ukvisionstrategy/page.asp?section =74 [Last accessed 2 March 2010]
19. West SK, Klein R, Rodriguez J, et al. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care 2001;24: 1204-1209
20. Varma R, Torres M, Pena F, et al. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology 2004;111:1298-1306
21. Roy MS, Klein R. Macular edema and retinal hard exudates in African Americans with type 1 diabetes: the New Jersey 725. Arch Ophthalmol 2001;119:251-259
22. Varma R, Klein R, West SK, et al. Are Latinos at greater risk for diabetic retinopathy than whites? Pooled findings from 3 population-based studies. Invest Ophthalmol Vis Sci 2005;46:1164
23. Flynn HW, Wong T, Mwamburi M, et al. Progression to proliferative diabetic retinopathy and severe visual impairment: a systematic review and meta-analysis [abstract]. Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting. May 3-7, Fort Lauderdale, FL
24. Henricsson M, Sellman A, Tyrberg M, et al. Progression to proliferative ret-inopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study. Acta Ophthalmol Scand 1999;77:218-222
25. Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macu-lar edema in persons with type 1 diabetes. Ophthalmology 2009;116: 497-503
26. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801-1815
27. Klein R, Moss SE, Klein BE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989;96:1501-1510
28. Klein R, Klein BE, Moss SE. The Wisconsin epidemiologic study of diabetic retinopathy: an update. Aust N Z J Ophthalmol 1990;18:19-22
29. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7-16
30. Klein R, Klein BE, Moss SE. How many steps of progression of diabetic ret-inopathy are meaningful? The Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 2001;119:547-553
31. Rossing K, Jacobsen P, Rossing P, et al. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care 1998;21:2007-2015
32. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9
33. Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994;101:1061-1070
34. Klein R, Lee KE, Knudtson MD, et al. Changes in visual impairment prevalence by period of diagnosis of diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 2009;116:1937-1942
35. Sjolie AK, Green A. Blindness in insulin-treated diabetic patients with age at onset less than 30 years. J Chronic Dis 1987;40:215-220
36. Jeppesen P, Bek T. The occurrence and causes of registered blindness in diabetes patients in Arhus County, Denmark. Acta Ophthalmol Scand 2004; 82:526-530
37. Grauslund J, Green A, Sjolie AK. Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patients. Ophthalmology 2009;116:2170-2174
38. Shea AM, Curtis LH, Hammill BG, et al. Resource use and costs associated with diabetic macular edema in elderly persons. Arch Ophthalmol 2008; 126:1748-1754
39. Lee LJ, Yu AP, Cahill KE, et al. Direct and indirect costs among employees with diabetic retinopathy in the United States. Curr Med Res Opin 2008; 24:1549-1559
40. Happich M, Reitberger U, Breitscheidel L, et al. The economic burden of diabetic retinopathy in Germany in 2002. Graefes Arch Clin Exp Ophthalmol 2008;246:151-159
41. Javitt JC, Aiello LP, Bassi LJ, et al. Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology. Ophthalmology 1991;98:1565-1573
42. Huang ES, Brown SE, Ewigman BG, et al. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007; 30:2478-2483
43. Lee DJ, Gomez-Marin O, Lam BL, et al. Visual impairment and morbidity in community-residing adults: the national health interview survey 1986-1996. Ophthalmic Epidemiol 2005;12:13-17
44. Varma R, Wu J, Chong K, et al. Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 2006; 113:1846-1853
45. Hariprasad SM, Mieler WF, Grassi M, et al. Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol 2008;92:89-92
46. Davidov E, Breitscheidel L, Clouth J, et al. Diabetic retinopathy and health-related quality of life. Graefes Arch Clin Exp Ophthalmol 2009;247:267-272
47. Tranos PG, Topouzis F, Stangos NT, et al. Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life. Curr Eye Res 2004;29:41-49